» Authors » Elda De Vita

Elda De Vita

Explore the profile of Elda De Vita including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 121
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cotugno S, De Vita E, Frallonardo L, Novara R, Papagni R, Asaduzzaman M, et al.
Ann Glob Health . 2025 Mar; 91(1):12. PMID: 40061583
Antimicrobial resistance (AMR) and migration are two interlinked issues and both pose an escalating threat to global health. With an increasing trend, there are 281 million migrants globally, while AMR...
2.
G G, Guido G, L F, Frallonardo L, Cotugno S, S C, et al.
Travel Med Infect Dis . 2025 Feb; 64:102823. PMID: 39983935
Background: Migration to Europe has intensified due to recent political conflicts, economic crises, and climate change, introducing an increased risk of neglected tropical diseases (NTDs) within this population. While NTDs...
3.
Segala F, Di Gennaro F, Frallonardo L, De Vita E, Petralia V, Sapienza V, et al.
Lancet HIV . 2024 Nov; 11(12):e833-e842. PMID: 39522535
Background: Compared with the general population, international migrants arriving in Europe face severe socioeconomic challenges that result in higher HIV prevalence and limited access to health care, potentially leading to...
4.
De Vita E, Segala F, Cavallin F, Guido G, Frallonardo L, Cotugno S, et al.
Front Med (Lausanne) . 2024 Sep; 11:1416904. PMID: 39318595
Introduction: The current Infectious Disease Society of America and American Thoracic Society (IDSA/ATS) guidelines recommend linezolid or vancomycin as an empiric treatment for methicillin-resistant (MRSA) pneumonia in hospitalized patients with...
5.
De Vita E, Limongi F, Veronese N, Di Gennaro F, Saracino A, Maggi S
Diseases . 2024 Aug; 12(8). PMID: 39195186
People with diabetes are at higher risk of serious complications from many vaccine-preventable diseases (VPDs). Some studies have highlighted the potential impact of glycosylated hemoglobin levels (HbA1c), but no systematic...
6.
De Vita E, Segala F, Frallonardo L, Civile G, De Scisciolo D, Novara R, et al.
Ann Glob Health . 2024 Jul; 90(1):46. PMID: 39070078
Nurses play a pivotal role in combating antimicrobial resistance (AMR). However, the success of local and national AMR containment efforts hinges on the knowledge, attitude, and practice (KAP) of nursing...
7.
Cotugno S, Guido G, Manco Cesari G, Ictho J, Lochoro P, Amone J, et al.
Am J Trop Med Hyg . 2024 Feb; 110(4):795-804. PMID: 38412542
Extrapulmonary tuberculosis (TB) is estimated to account for up to 20% of active cases of TB disease, but its prevalence is difficult to ascertain because of the difficulty of diagnosis....
8.
Di Gennaro F, Guido G, Frallonardo L, Segala F, De Nola R, Damiani G, et al.
BMC Infect Dis . 2023 Nov; 23(1):776. PMID: 37946100
Background: Clinical evidence suggests that pregnant women are more vulnerable to COVID-19, since they are at increased risk for disease progression and for obstetric complications, such as premature labor, miscarriage,...
9.
Segala F, Patti G, Olal L, De Vita E, Olung N, Papagni R, et al.
Am J Trop Med Hyg . 2023 Nov; 109(6):1363-1367. PMID: 37931305
Both SARS-CoV2 and Plasmodium falciparum infection during pregnancy increases the risk for adverse maternal and fetal outcomes, including abortion, severe disease, and death. Indeed, although malaria and COVID-19 show an...
10.
Segala F, Ictho J, LEpiscopia M, Onapa E, De Vita E, Novara R, et al.
Pathog Glob Health . 2023 Oct; 118(3):253-261. PMID: 37872763
Background: Pregnancy is both a risk factor for infection and development of severe malaria. In low- and middle-income countries, the COVID-19 pandemic severely impacted health systems, including utilization of maternal...